Author:
Winer Eric S.,Safran Howard,Karaszewska Boguslawa,Bauer Sebastian,Khan Dilawar,Doerfel Steffen,Burgess Paul,Kalambakas Stacey,Mostafa Kamel Yasser,Forget Frederic
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology. 2015;29:282–94.
2. Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000–2007. Clin Ther. 2009;31:2416–32.
3. Cairo MS. Dose reductions and delays: limitations of myelosuppressive chemotherapy. Oncology. 2000;14:21–31.
4. Choi JH, Oh SY, Kwon HC, Kim JH, Lee JH, Lee S, et al. Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis. Cancer Res Treat. 2008;40:22–6.
5. Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, et al. Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27:3778–85.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献